Vanda Pharmaceuticals (VNDA) Q2 2014 Results - Earnings Call Webcast

Aug. 7.14 | About: Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (NASDAQ:VNDA): Q2 EPS of -$0.64 beats by $0.09. Revenue of $10.9M (+31.0% Y/Y) beats by $0.9M.

The following audio is from a conference call that will begin on August 07, 2014 at 10:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.